Intra Versus Extrahepatic Division of Right Hepatic Vein During Rightsided Hemihepatectomy
NCT ID: NCT02041078
Last Updated: 2017-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
100 participants
INTERVENTIONAL
2011-05-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy
NCT00200148
Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection
NCT02769754
Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection
NCT01651182
The Major Bleeding Risk Following Hepatectomy
NCT04748081
Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy
NCT00657384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extrahepatic vein division
Conventional right sided hemihepatectomy with division of the liver parenchyma with CUSA.
Extrahepatic vein division
Standard surgical procedure with extrahepatic ligation/division of the right hepatic vein prior to parenchymal division with CUSA.
Intrahepatic vein division
Conventional right sided hemihepatectomy with division of the liver parenchyma with CUSA and intrahepatic division of the right hepatic vein.
Intrahepatic division of the right hepatic vein.
Ligation and division of the entrance of the right hepatic vein into the suprarenal cava vein are done at the end of transection of the liver parenchyma with CUSA.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrahepatic division of the right hepatic vein.
Ligation and division of the entrance of the right hepatic vein into the suprarenal cava vein are done at the end of transection of the liver parenchyma with CUSA.
Extrahepatic vein division
Standard surgical procedure with extrahepatic ligation/division of the right hepatic vein prior to parenchymal division with CUSA.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unfit for surgery
* Unwillingness to participate
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jansson, Anders, M.D.
INDIV
Bengt Isaksson
UNKNOWN
Karolinska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars Lundell
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars Lundell, Professor
Role: PRINCIPAL_INVESTIGATOR
Gastrocentrum Karolinska University Hospital Huddinge, 141 86 Stockholm
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery Gastrocentrum Karolinska Univeristy Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011/563-31/2
Identifier Type: OTHER
Identifier Source: secondary_id
2011/563-31/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.